239 Users Online
Circadian Rhythm Sleep Treatment Market Segmented By Delayed Sleep Phase Syndrome, Advanced Sleep Phase Syndrome, Non–24-h sleep-wake syndrome, Irregular Sleep-Wake Disorder, Shift Work Disorder Disorder
Circadian Rhythm Sleep Treatment Market witnessed a CAGR of 4.6% between 2013 and 2021. The global Circadian Rhythm Sleep Treatment Market is expected to witness a 4.7%CAGR between 2022 and 2026. In 2022, the global Circadian Rhythm Sleep Treatment Market size was US$ 714.7 million, which is projected to reach US$ 857.8 million by the year 2026.
| Attribute | Key Insights |
|---|---|
|
Cardiac Marker Analyzer Market Size (2022) |
US$ 714.7 Mn |
|
Projected Market Value (2026) |
US$ 857.8 Mn |
|
Global Market Growth Rate (2022-2026) |
4.7%CAGR |
|
Share in parent market |
23.1 |
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Circadian Rhythm Sleep Treatment Market is expected to witness at a CAGR of 4.7% during the forecast period between 2022 and 2026. The rise in sleep disorders and rapidly changing lifestyle are contributing to the increasing demand for Circadian Rhythm Sleep Treatments. Furthermore, product development in therapeutic devices and drug adoption for circadian rhythm sleep treatment is expected to drive the global Circadian Rhythm Sleep Treatment Market.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionThe need for proper sleep treatment has increased due to the growing prevalence of sleep disorders such as Delayed Sleep Phase Syndrome, Advanced Sleep Phase Syndrome, Non–24-h sleep-wake syndrome, and others, is contributing to significant growth in the Circadian Rhythm Sleep Treatment Market growth globally. Furthermore, product development in therapy devices and adoption of drugs for circadian rhythm sleep treatment are the factors expected to boost the circadian rhythm sleep treatment market.
Accidents and human mishaps are commonly related to sleep issues. The number of people killed in car accidents is expected to double to 2.3 million globally, with 230,000–345,000 deaths caused by exhaustion or drowsiness. Similarly, disrupted sleep is projected to increase the chance of a deadly workplace accident. As a result of the increased risk of fatal accidents caused by disrupted sleep, the treatment rate rises, driving the worldwide circadian rhythm sleep treatment market forward.
The lack of awareness about the key concerns associated with circadian rhythm sleep disorders among people in underdeveloped nations may stifle the expansion of the circadian rhythm sleep treatment market. Furthermore, carelessness towards drug side effects and sleep problems might impede the growth of the circadian rhythm sleep treatment market.
Sales Team
Client Partner
“Decrease in demand due to lockdown”
The COVID-19 pandemic had a negative impact on the global economy, and it had a significant impact on the Circadian Rhythm Sleep Treatment Market. Due to strict lockdown, doctors shifted to tele-medicine as the hospitals were flooded with virus patients. Apart from this due to the stringent lockdown regulations and disruptions in the supply chain activities there was a decrease in the availability and sales of Circadian Rhythm Sleep Treatment devices around the world. However, the global Circadian Rhythm Sleep Treatment industry stabilized after 2021.
The Circadian Rhythm Sleep Treatment industry is very competitive and highly consolidated due to the presence of several large players. Key players in the market are focusing on mergers and acquisitions as the industry is in the growth phase. Companies are making strategic decisions to engage in mergers and acquisitions in order to expand their product portfolios and grow their market share.
Along with inorganic modes of expansion, organic modes are also being looked upon as feasible means. Continuous innovation is actually the lifeline of circadian rhythm sleep treatment market and the status quo is expected to remain the same even in the forecast period (2022-2026).
| Attribute | Details |
|---|---|
|
Forecast Period |
2022-2026 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
US$ Mn/Bn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
By Disorder |
|
Key Companies Profiled |
|
|
Customization & Pricing |
Available upon Request |
Circadian Rhythm Sleep Treatment Market by Disorder
Circadian Rhythm Sleep Treatment Market by Region
In 2022, the Circadian Rhythm Sleep Treatment Market stands at USD 717.4 million, and it is expected to reach USD 857.8 million by 2026 at a CAGR of 4.7%.
Circadian Rhythm Sleep Treatment Market exhibited a 4.6% CAGR between 2013 and 2021.
The lack of awareness about the key concerns associated with circadian rhythm sleep disorders among people is the key restraint in the Cardiac Marker Analyzer Market.
An increase in the number of sleep disorders and rapid change in the lifestyles are the key factors driving the growth of the market.
Natus Medical Incorporated, Compumedics Ltd., Teva Pharmaceutical Industries Ltd, and Takeda Pharmaceutical Company are among the top players in the market.
